| Ferrari, Gaetano De |
| Recruiting | 3 | 80 | Europe | Colchicine, Treatment, Placebo | Niguarda Hospital, European Union, Ministry of Health, Italy, Mario Negri Institute for Pharmacological Research, University of Milano Bicocca | Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart Failure, Ventricular Arrythmia | 05/26 | 05/28 | | |
| Recruiting | 3 | 288 | Europe, US, RoW | Methylprednisolone, saline solution | Niguarda Hospital, Ministry of Health, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, University of Milano Bicocca, Regione Lombardia | Myocarditis Acute | 03/28 | 12/28 | | |
POPSTAR, NCT06294782: PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia |
|
|
| Recruiting | N/A | 30 | Europe | STereotactic Arhythmia Radioablation (STAR) | University of Turin, Italy, Azienda Unità Sanitaria Locale Reggio Emilia, IRCCS Sacro Cuore Don Calabria di Negrar, Fondazione IRCCS Policlinico San Matteo di Pavia | Refractory Ventricular Tachycardia | 02/25 | 02/25 | | |
LIVE, NCT04168970: Percutaneous Left Stellate Ganglion Block In Out-of-hospital Cardiac Arrest Due to Refractory VEntricular Arrhythmias ( Study) |
|
|
| Recruiting | N/A | 53 | Europe | PSGB | IRCCS Policlinico S. Matteo, Azienda Regionale Emergenza Urgenza (AREU), University of Pavia | Out-Of-Hospital Cardiac Arrest, Ventricular Fibrillation Sustained | 07/25 | 07/25 | | |
| Recruiting | N/A | 10000 | Europe | | Heart Care Foundation | Heart Failure | 06/26 | 07/26 | | |
| Recruiting | N/A | 100 | Europe | Percutaneous stellate ganglion block (PSGB) | IRCCS Policlinico S. Matteo | Arrhythmic Storm | 12/25 | 12/25 | | |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
NCT04433052: Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD |
|
|
| Recruiting | N/A | 12000 | Europe | personalised prevention program (PPP) | Tampere University | Coronary Heart Disease | 12/26 | 12/26 | | |
